{
      "ptx_code": "PTX088",
      "chem_name": "Fipronil",
      "casrn": "120068-37-3",
      "dtxsid": "DTXSID4034609",
      "smiles": "NC1=C(C(=NN1C1=C(Cl)C=C(C=C1Cl)C(F)(F)F)C#N)S(=O)C(F)(F)F",
      "inchikey": "ZOCSXAVNDGMNBV-UHFFFAOYSA-N",
      "label": "PTX088 | Fipronil",
      "drugbank_id": "",
      "use_class": "Pesticide",
      "tox_class": "Nephrotoxicity; Hepatotoxicity; Neurotoxicity; Immunotoxicity; Genotoxicity",
      "chem_name_user": "Fipronil",
      "mw_g_mol": "437.14",
      "solubility_h2o_mol_liter": "6.17e-06",
      "source_solubility_h2o": "COMPTOX (OPERA)",
      "henry_coefficient_atm_m3_mol": "9.16e-09",
      "source_henry": "COMPTOX",
      "log_kaw_kh_rt": "6.43",
      "source_kaw": "Comptox",
      "pka_acid": "",
      "pka_base": "",
      "source_pka": "ACD pKa/GALAS",
      "log_kow_liter_liter": "4.00",
      "source_kow": "experimental  PhysPropNCCT",
      "log_dlipw_ph74_liter_liter": "4.16",
      "source_dlipw": "Kow-QSAR (?mw=1)",
      "freely_dissolved_fraction": "0.13",
      "density_kg_liter": "1.91",
      "source_density": "COMPTOX",
      "baseline_drerio": "12.60",
      "baseline_dmagna": "13.30",
      "baseline_celegans": "29.51",
      "baseline_xlaevis": "22.30",
      "baseline_dmelanogaster": "112.56",
      "baseline_cells": "1.34e-05",
      "baseline_cells_generic_micromole_liter_free_ec10": "1.80e-06",
      "moa_drugbank": "",
      "protein_binding": "",
      "moa_t3db": "Fipronil blocks the passage of chloride ions through the GABA-regulated chloride channel, disrupting CNS activity. (T10); Causes endocrine disruption in humans by binding to and inhibiting the estrogen receptor. (A590)",
      "aop": [
            {
                  "AOP_id": 19,
                  "AOP_name": "Androgen receptor antagonism leading to adverse effects in the male foetus (mammals) "
            },
            {
                  "AOP_id": 34,
                  "AOP_name": "LXR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 58,
                  "AOP_name": "NR1I3 (CAR) suppression leading to hepatic steatosis "
            },
            {
                  "AOP_id": 72,
                  "AOP_name": "Epigenetic modification of PPARG leading to adipogenesis "
            }
      ],
      "targets": [
            "C-C motif chemokine 2",
            "C-X-C motif chemokine 10",
            "Cytochrome P450 2B6",
            "Cytochrome P450 3A4",
            "Estrogen receptor alpha",
            "Estrogen receptor beta",
            "Gamma-aminobutyric acid receptor subunit alpha-1",
            "Gamma-aminobutyric acid receptor subunit alpha-2",
            "Gamma-aminobutyric acid receptor subunit alpha-3",
            "Gamma-aminobutyric acid receptor subunit alpha-4",
            "Gamma-aminobutyric acid receptor subunit alpha-5",
            "Gamma-aminobutyric acid receptor subunit alpha-6",
            "Gamma-aminobutyric acid receptor subunit beta-1",
            "Gamma-aminobutyric acid receptor subunit beta-2",
            "Gamma-aminobutyric acid receptor subunit beta-3",
            "Gamma-aminobutyric acid receptor subunit delta",
            "Gamma-aminobutyric acid receptor subunit epsilon",
            "Gamma-aminobutyric acid receptor subunit gamma-1",
            "Gamma-aminobutyric acid receptor subunit gamma-2",
            "Gamma-aminobutyric acid receptor subunit gamma-3",
            "Gamma-aminobutyric acid receptor subunit theta",
            "Interstitial collagenase",
            "Multidrug resistance protein 1",
            "Nuclear factor erythroid 2-related factor 2",
            "Nuclear receptor subfamily 1 group I member 2",
            "Nuclear receptor subfamily 1 group I member 3",
            "Plasminogen activator inhibitor 1",
            "Tumor necrosis factor receptor superfamily member 10B",
            "Urokinase plasminogen activator surface receptor"
      ]
}